NASDAQ:HTBX
Delisted
Heat Biologics Stock News
$2.38
+0 (+0%)
At Close: Aug 17, 2022
Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
12:00pm, Wednesday, 27'th May 2020
DURHAM, NC / ACCESSWIRE / May 27, 2020 / Heat Biologics, Inc. ("Heat") (HTBX), a clinical-stage biopharmaceutical company specialized in the development of novel therapeutic and prophylactic vaccines,
Takeda's Approval And Other News: The Good, Bad And Ugly Of Biopharma (NYSE:TAK)
12:39pm, Monday, 25'th May 2020
Takeda's brigatinib is approved for a type of non-small cell lung cancer, or NSCLC. Zealand Pharma's NDA for Hypopal rescue pen is accepted. EvoFem's contracept
Takeda Pharmaceutical Company Limited (Bolsa de Valores de Tokio:4502/Bolsa de Valores de Nueva York:TAK) anunció hoy que la Administración de Aliment
Week In Review: CanSino Publishes Positive Data From Trial Of COVID-19 Vaccine
02:47pm, Sunday, 24'th May 2020
Moderna, a Boston-area mRNA company, reported positive early data from a Phase I trial of its coronavirus vaccine. Sinovac Biotech of Beijing raised $15 million
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) gab heute bekannt, dass die US-amerikanische Arzneimittelbehörde (Food and Drug Administrati
Mulling Over Mersana Therapeutics (NASDAQ:MRSN)
06:34pm, Friday, 22'nd May 2020
Today we offer up an in-depth look at Mersana Therapeutics which recently executed two large ATMs on the same day, raising gross proceeds of $65 million. Interi
Xconomy: Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More
02:40pm, Friday, 22'nd May 2020
As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists
A Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) anunciou hoje que a empresa apresentará os dados de seu pipeline de oncologia
EN DIRECT DES MARCHES : Air France, Ubisoft, Eurazeo, Solocal, Genfit, Uber, Disney, Moderna...
12:10pm, Tuesday, 19'th May 2020
Die Janssen Pharmaceutical Companies of Johnson & Johnson gaben heute Ergebnisse aus der Phase-1-Studie CHRYSALIS bekannt, die Amivantamab (JNJ-63
Roche's Tecentriq wins FDA approval as first-line therapy for some...
09:17pm, Monday, 18'th May 2020
May 18 (Reuters) - Swiss drugmaker Roche Holding AG's Genentech unit said on Monday the U.S. Food and Drug Administration has approved Tecentriq as a...
We're Keeping An Eye On Heat Biologics's (NASDAQ:HTBX) Cash Burn Rate
11:45am, Monday, 18'th May 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
